JP2014523851A5 - - Google Patents

Download PDF

Info

Publication number
JP2014523851A5
JP2014523851A5 JP2013546480A JP2013546480A JP2014523851A5 JP 2014523851 A5 JP2014523851 A5 JP 2014523851A5 JP 2013546480 A JP2013546480 A JP 2013546480A JP 2013546480 A JP2013546480 A JP 2013546480A JP 2014523851 A5 JP2014523851 A5 JP 2014523851A5
Authority
JP
Japan
Prior art keywords
group
substituted
optionally substituted
ring
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013546480A
Other languages
English (en)
Japanese (ja)
Other versions
JP5976011B2 (ja
JP2014523851A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013546480A priority Critical patent/JP5976011B2/ja
Priority claimed from PCT/JP2012/059949 external-priority patent/WO2012137982A2/en
Publication of JP2014523851A publication Critical patent/JP2014523851A/ja
Publication of JP2014523851A5 publication Critical patent/JP2014523851A5/ja
Application granted granted Critical
Publication of JP5976011B2 publication Critical patent/JP5976011B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013546480A 2011-04-05 2012-04-05 スルホンアミド誘導体およびその用途 Active JP5976011B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013546480A JP5976011B2 (ja) 2011-04-05 2012-04-05 スルホンアミド誘導体およびその用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011084100 2011-04-05
JP2011084100 2011-04-05
PCT/JP2012/059949 WO2012137982A2 (en) 2011-04-05 2012-04-05 Sulfonamide derivative and use thereof
JP2013546480A JP5976011B2 (ja) 2011-04-05 2012-04-05 スルホンアミド誘導体およびその用途

Publications (3)

Publication Number Publication Date
JP2014523851A JP2014523851A (ja) 2014-09-18
JP2014523851A5 true JP2014523851A5 (enExample) 2015-05-21
JP5976011B2 JP5976011B2 (ja) 2016-08-23

Family

ID=46028103

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546480A Active JP5976011B2 (ja) 2011-04-05 2012-04-05 スルホンアミド誘導体およびその用途

Country Status (4)

Country Link
US (1) US9527807B2 (enExample)
EP (1) EP2694472B1 (enExample)
JP (1) JP5976011B2 (enExample)
WO (1) WO2012137982A2 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9493484B2 (en) 2012-02-08 2016-11-15 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JO3225B1 (ar) * 2012-11-27 2018-03-08 Lilly Co Eli 6-((s)-1-{1-[5-(2-هيدروكسي-إيثوكسي)-بيريدين-2-يل]-1h-بيرازول-3-يل}إيثيل)-3h-1 ، 3-بنزو ثيازول-2- أون باعتباره مضاد مستقبل ampa يعتمد على tarp- جاما 8
EP3015458A1 (en) * 2014-11-03 2016-05-04 Bayer CropScience AG Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines
BR112016021874B1 (pt) 2014-03-24 2021-03-23 Bayer Cropscience Aktiengesellschaft Processo para preparar derivados de 3,5-bis(haloalquil)pirazol a partir de alfa,alfa-dihaloaminas e cetiminas e compostos
SG11201806429PA (en) * 2016-02-04 2018-08-30 Takeda Pharmaceuticals Co Substituted piperidine compound and use thereof
EP3436021B1 (en) 2016-03-29 2026-07-29 RespireRx Pharmaceuticals, Inc. Compositions comprising low impact ampakines for treating attention deficit disorders
AR108838A1 (es) 2016-06-21 2018-10-03 Bristol Myers Squibb Co Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
JP7012703B2 (ja) 2017-03-08 2022-02-14 武田薬品工業株式会社 置換ピロリジン化合物およびその用途
JP6957598B2 (ja) 2017-03-08 2021-11-02 武田薬品工業株式会社 置換ピロリジン化合物およびその用途
US10428023B2 (en) 2017-08-03 2019-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US11319286B2 (en) 2017-08-03 2022-05-03 Takeda Pharmaceutical Company Limited Heterocyclic compound and application thereof
US11407748B2 (en) 2017-10-06 2022-08-09 Takeda Pharmaceutical Company Limited Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
EP3693360B1 (en) 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
JP7369125B2 (ja) 2017-12-19 2023-10-25 ブリストル－マイヤーズ スクイブ カンパニー Ｌｐａアンタゴニストとしてのイソキサゾールｏ－架橋カルバモイルシクロヘキシル酸
CA3085561A1 (en) 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Cyclohexyl acid triazole azines as lpa antagonists
US11319309B2 (en) 2017-12-19 2022-05-03 Bristol-Myers Squibb Company Cyclohexyl acid isoxazole azines as LPA antagonists
PE20210655A1 (es) 2017-12-19 2021-03-31 Bristol Myers Squibb Co Carbamoil ciclohexil acidos ligados a n de triazol como antagonistas de lpa
WO2019126087A1 (en) 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Cyclohexyl acid isoxazole azoles as lpa antagonists
US11447475B2 (en) 2017-12-19 2022-09-20 Bristol-Myers Squibb Company Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
CN111712492B (zh) 2017-12-19 2024-05-31 百时美施贵宝公司 作为lpa拮抗剂的环己基酸三唑唑类
EA039459B1 (ru) * 2017-12-25 2022-01-28 Такеда Фармасьютикал Компани Лимитед Гетероциклическое соединение и его применение в качестве средства для лечения заболеваний, связанных с рецептором орексина 2 типа
CN111801096B (zh) * 2018-03-20 2024-03-05 卫材R&D管理有限公司 癫痫治疗剂
US11655241B2 (en) 2018-06-29 2023-05-23 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
EP3816154B1 (en) 2018-06-29 2025-04-23 Takeda Pharmaceutical Company Limited Heterocyclic compound and application thereof
ES2946657T3 (es) 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
KR102800284B1 (ko) 2018-09-18 2025-04-23 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 시클로헵틸 산
JP7379374B2 (ja) 2018-12-12 2023-11-14 武田薬品工業株式会社 複素環化合物
JP7408569B2 (ja) * 2018-12-12 2024-01-05 武田薬品工業株式会社 複素環化合物
PE20211700A1 (es) 2019-01-31 2021-09-01 Takeda Pharmaceuticals Co Compuesto heterociclico y su uso
US11098029B2 (en) 2019-02-13 2021-08-24 Merck Sharp & Dohme Corp. 5-alkyl pyrrolidine orexin receptor agonists
WO2020167701A1 (en) 2019-02-13 2020-08-20 Merck Sharp & Dohme Corp. Pyrrolidine orexin receptor agonists
US12466804B2 (en) 2019-06-18 2025-11-11 Bristol-Myers Squibb Company Cyclobutyl carboxylic acids as LPA antagonists
EP3986552B1 (en) 2019-06-18 2024-09-18 Bristol-Myers Squibb Company Isoxazole carboxylic acids as lpa antagonists
KR20220024548A (ko) 2019-06-18 2022-03-03 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 트리아졸 카르복실산
EP4010314B1 (en) 2019-08-08 2024-02-28 Merck Sharp & Dohme LLC Heteroaryl pyrrolidine and piperidine orexin receptor agonists
KR20260083444A (ko) 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
WO2021106975A1 (ja) 2019-11-27 2021-06-03 武田薬品工業株式会社 複素環化合物
US20230365533A1 (en) 2020-08-18 2023-11-16 Merck Sharp & Dohme Llc Bicycloheptane pyrrolidine orexin receptor agonists
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
WO2022207935A1 (en) 2021-04-02 2022-10-06 Orexia Therapeutics Limited 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists
JP7833486B2 (ja) 2021-05-26 2026-03-19 アルカーメス，インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
JP2025510384A (ja) 2022-03-28 2025-04-14 バイエル アクチェンゲゼルシャフト シス－４－アミノテトラヒドロフラン－２－カルボン酸エステルの調製方法
US20250250230A1 (en) 2022-04-12 2025-08-07 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP2025521507A (ja) * 2022-06-21 2025-07-10 アルカームス インコーポレーテッド 置換縮合二環式化合物および関連する治療方法
WO2023249871A1 (en) * 2022-06-21 2023-12-28 Alkermes, Inc. Substituted pyrrolidinyl and piperidinyl compounds and related methods of treatment
CA3260225A1 (en) * 2022-06-21 2023-12-28 Alkermes, Inc. Fused, Substituted Bicyclic Compounds and Associated Treatment Methods
TW202409023A (zh) 2022-07-14 2024-03-01 美商富曼西公司 除草苯并𠯤
CN115433102B (zh) * 2022-10-16 2024-02-27 大连双硼医药化工有限公司 一种反式-(1r,2r)-2-氨基环己烷羧酸乙酯盐酸盐的制备方法
PE20251923A1 (es) 2022-10-31 2025-08-05 Takeda Pharmaceutical Co Limited Compuesto heterociclico
WO2024116086A1 (en) 2022-11-30 2024-06-06 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
EP4680611A1 (en) 2023-03-16 2026-01-21 Takeda Pharmaceutical Company Limited Macrocyclic heterocycle compounds and use thereof
AU2024387082A1 (en) 2023-11-21 2026-06-04 Fmc Corporation Substituted tetrahydroquinoline and tetrahydroquinoxaline herbicides
WO2025229494A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2025229495A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Heterocyclic compound

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2765322A (en) 1953-03-03 1956-10-02 Rohm & Haas Preparation of bis(4-glycidyloxyphenyl)-sulfone
US5315013A (en) 1988-01-07 1994-05-24 E. I. Du Pont De Nemours And Company Substituted pyrazole angiotensin II antagonists
RU2200730C2 (ru) 1996-07-31 2003-03-20 Шионоги Энд Ко., Лтд. Пара-терфенильные соединения, способ их получения (варианты) и фармацевтическая композиция (варианты)
DE19803396A1 (de) 1998-01-29 1999-08-05 Bayer Ag Substituierte Phenyluracile
WO1999060652A1 (en) 1998-05-20 1999-11-25 Osaka Gas Company Limited Nonaqueous secondary cell and method for controlling the same
KR100682276B1 (ko) * 1998-07-24 2007-02-28 데이진 가부시키가이샤 안트라닐산 유도체
BR0012068A (pt) * 1999-06-30 2002-05-14 Daiichi Seiyaku Co Compostos inibidores de vla-4
BR0307409A (pt) 2002-02-01 2004-12-28 Dainippon Pharmaceutical Co Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
JP2003238538A (ja) 2002-02-12 2003-08-27 Nippon Nohyaku Co Ltd 新規４−置換フェニル−５−ハロピリミジン誘導体及びこれを有効成分とする除草剤
JP2005060385A (ja) 2003-07-31 2005-03-10 Dainippon Pharmaceut Co Ltd ２−フランカルボン酸ヒドラジド化合物からなる医薬
BRPI0514191A (pt) 2004-08-09 2008-06-03 Glaxo Group Ltd compostos que potencializam o receptor glutamato e seus usos em medicina
JP2008509179A (ja) 2004-08-09 2008-03-27 グラクソ グループ リミテッド グルタミン酸受容体を強化する化合物および医学におけるその使用
GB0417709D0 (en) 2004-08-09 2004-09-08 Glaxo Group Ltd Compounds
EP1849465A4 (en) 2005-02-18 2008-12-24 Takeda Pharmaceutical AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR
UA92007C2 (ru) 2005-05-04 2010-09-27 Н.В. Органон Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности
DE602006003661D1 (de) 2005-06-06 2008-12-24 Lilly Co Eli Ampa-rezeptoren-verstärker
EP1906952A4 (en) 2005-07-01 2010-04-14 Jenrin Discovery MAO-B-HEMMER FOR THE TREATMENT OF ADIPOSITAS
JP5014334B2 (ja) * 2005-10-06 2012-08-29 イーライ リリー アンド カンパニー Ａｍｐａ受容体増強剤
GB0602560D0 (en) 2006-02-08 2006-03-22 Glaxo Group Ltd Compounds
EP1981865A1 (en) 2006-02-08 2008-10-22 Glaxo Group Limited 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
AU2007333247B2 (en) 2006-12-11 2012-06-07 Eli Lilly And Company AMPA receptor potentiators
WO2008113795A1 (en) 2007-03-20 2008-09-25 Glaxo Group Limited Compounds which potentiate ampa receptor and uses thereof in medicine
WO2008120093A1 (en) 2007-04-03 2008-10-09 Pfizer Inc. Sulfonamides and pharmaceutical compositions thereof
JP2011506551A (ja) 2007-12-19 2011-03-03 グラクソ グループ リミテッド Ａｍｐａ受容体増強化合物および医薬におけるその使用
GB0801220D0 (en) 2008-01-23 2008-02-27 Glaxo Group Ltd Compounds
GB0801265D0 (en) 2008-01-23 2008-02-27 Glaxo Group Ltd Compounds
CA2718727A1 (en) 2008-03-25 2009-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
US20110178165A1 (en) 2008-10-08 2011-07-21 Pfizer Inc. Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
CN102365265A (zh) 2009-04-09 2012-02-29 欧加农股份有限公司 2，3-二氢化茚衍生物
AU2010264095B2 (en) 2009-06-26 2013-07-11 Biogen Ma Inc. Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
AU2010274921B2 (en) * 2009-07-23 2014-08-14 Novartis Ag 1H-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis
WO2012020848A1 (en) 2010-08-10 2012-02-16 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof

Similar Documents

Publication Publication Date Title
JP2013528204A5 (enExample)
DK1700856T3 (en) thiazole
JP2018524390A5 (enExample)
JP2015500861A5 (enExample)
JP2017502940A5 (enExample)
JP2017505293A5 (enExample)
JP2014526435A5 (enExample)
JP2017504631A5 (enExample)
JP2016538313A5 (enExample)
CA2903288A1 (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP2016515560A5 (enExample)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2016534134A5 (enExample)
HRP20201171T1 (hr) Derivati izoindolin-1-ona kao modulatori aktivnosti pozitivnog alosternog modulatora kolinergijskog muskarinskog m1 receptora za liječenje alzheimerove bolesti
JP2014530900A5 (enExample)
JP2014511891A5 (enExample)
JP2014508804A5 (enExample)
JP2014534981A5 (enExample)
JP2013531070A5 (enExample)
JP2016514117A5 (enExample)
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
JP2013525356A5 (enExample)
RU2017120217A (ru) 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1
RU2013125338A (ru) Производные триазола в качестве лигандов рецепторов гамк
JP2016512227A5 (enExample)